Skip to main content
Seaport Therapeutics, Inc. logo

Seaport Therapeutics, Inc. — Investor Relations & Filings

Ticker · SPTX ISIN · US81221K1088 Manufacturing
Filings indexed 15 across all filing types
Latest filing 2026-05-12 Major Shareholding Noti…
Country US United States of America
Listing SPTX

About Seaport Therapeutics, Inc.

https://seaporttx.com/

Seaport Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on inventing and developing novel neuropsychiatric medicines. The company advances antidepressants and anxiolytics for patients with depression and anxiety, addressing areas of high unmet medical need. Seaport Therapeutics leverages its proprietary Glyph This is a clinical-stage biopharmaceutical company focused on advancing novel antidepressants and anxiolytics based on clinically validated mechanisms using its Glyph™ platform.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2026
Major Shareholding Notification
2026-05-12 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-05-06 English
8-K
Regulatory Filings
2026-05-04 English
S-8
Registration Form
2026-05-02 English
424B4
Prospectus
2026-05-01 English
Regulatory Filings 2026
Regulatory Filings
2026-05-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.